The high mortality rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
infection is a critical concern of the coronavirus disease 2019 (COVID-19) pandemic …

Background It has been reported that people with COVID‐19 and pre‐existing
autoantibodies against type I interferons are likely to develop an inflammatory cytokine storm …

Objectives Cytokine release syndrome with elevated interleukin-6 (IL-6) levels is associated
with multiorgan damage and death in severe coronavirus disease 2019 (COVID-19). Our …

SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which
remains ill defined. We analyzed 85 SARS-CoV-2-infected individuals at acute and/or …

The pleiotropic cytokine interleukin-6 (IL-6) has been implicated in the pathogenesis of
COVID-19, but uncertainty remains about the potential benefits and harms of targeting IL-6 …

Importance Psychiatric outcomes after COVID-19 have been of high concern during the
pandemic; however, studies on a nationwide level are lacking. Objective To estimate the risk …

Coronavirus disease 2019 (COVID-19) is a condition caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Severe cases of COVID-19 result in acute …

The highly infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
emerged as the causative agent of coronavirus disease 2019 (COVID-19) in late 2019 …

Abstract Leucine-rich α-2-glycoprotein 1 (LRG1) is a secreted glycoprotein that under
physiological conditions is produced predominantly by the liver. In disease, its local …

In the lungs of infected individuals, the downstream molecular signaling pathways induced
by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) are incompletely …